TXG · 10x Genomics, Inc.
$56.09
-2.06 (-3.54%)
At close · Aug 14
Market Cap
$7.31B
Shares
130.29M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2017-12-31 | $80,000 | 10-K, filed 2020-02-27 |
Key facts
CIK
1770787
CUSIP
88025U109
13F (30d)
365 filings
356 filers
Visit website
Investor relations